-
S&P 500 breaks above February highs
-
Blurry inflation landscape supports Treasury yields.
Wall Street trades with a great dose of optimism on Friday, following “not so tragic” inflation data, which, combined with hopes of closing major trade deals, soothe worries of tariff-driven inflationary spiral. The S&P 500 ticks up 0.5%, breaking over the mid-February peak (currently at 6172). Other major indices are also in the green (DJIA: +0.7%, Nasdaq: +0.5%, Russell 2000: 0.35%).
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appCore PCE inflation rose by 0.2% in May, pushing the annual rate to 2.7% and slightly surpassing expectations. While headline inflation remained modest, the sticky core reading highlights the ongoing difficulty in steering inflation back to the Fed’s 2% target. This reinforces the Fed’s cautious stance, as reflected in today’s market reaction, with the decline in the 10-year Treasury yield coming to a halt.
Volatility in S&P 500 sectors. Source: Bloomberg Finance LP
US100 (H1)
The US100 index futures contract is diving nearly 100 points today from its all-time high at 22,787. However, it quickly recovers about 50% of the drop. Technical indicators currently suggest a mostly neutral stance toward the market. Among the indicators shown on the chart, only the 25-period Exponential Moving Average (EMA 25) signals potential upside, as the price has bounced off this level.
Meanwhile, the RSI, MACD, and Bollinger Bands show no clear directional signal — the RSI remains within the 30–70 range, the MACD is hovering near the signal line, and the price is positioned right in the middle of the Bollinger Bands.
Nonetheless, further gains in the US100 cannot be ruled out as long as no significant and unexpected geopolitical events occur and until next week's key macroeconomic data potentially shifts investor sentiment.
Source: xStation 5
Company News:
-
Nike (NKE.US) surged over 15% after reporting better-than-expected sales trends and receiving several price target upgrades. Analysts see signs of a turnaround as the company focuses on cleaning up inventories and stabilizing margins.
-
Atlantic Union Bankshares adds 1% following the sale of $2 billion in commercial real estate loans to Blackstone. The move allows the bank to lower funding costs and strengthen its securities portfolio.
-
BioCryst (BCRX.US) is down 1.5% after selling its European Orladeyo business for up to $264M to Neopharmed Gentili. The proceeds will be used to eliminate debt and improve operating margins.
-
Li Auto (LI.US) dropped 3% after cutting its Q2 vehicle delivery forecast due to a temporary sales system upgrade. However, the company reaffirmed long-term confidence tied to the upcoming Li i8 model.
-
CorMedix plummeted 18% as it priced a share offering at up to $13.09, a 14% discount to Thursday’s close. The funds will support working capital and strategic projects.
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
